...
As scientific director, Parkman oversaw all of the CBER scientific programs and its intramural research, and he served as a principal liaison with the scientific community. During his tenure as center director, among other activities, the Center CBER approved a Haemophilus b conjugate vaccine for the most common cause of bacterial meningitis in children as young as 18 months. The FDA also doubled the number of inspections of blood banks and concluded an agreement for improved blood processing operations across the nation—actions that followed the recall of two dozen units from two American Red Cross collection centers that indicated exposure to HIV and hepatitis B. Under Under Parkman, the Center CBER developed guidelines to design clinical studies to assess safety and efficacy of allergenic products and it licensed tests to detect antibodies in blood to the Human T-Lymphotropic Virus Type I (HTLV-I) retrovirus.
...
Overview
Content Tools
ThemeBuilder